Press Releases

All Releases
Oct 07, 2010
AngioDynamics Reports Fiscal 2011 First Quarter Financial Results

<ul>
<li class="bwlistitemmargb">
<i><b>Net Sales of $51.5 Million</b></i>
</li>
<li class="bwlistitemmargb">
<i><b>Net Income of $1.9 Million, or $0.08 EPS</b></i>
</li>
<li class="bwlistitemmargb">
<i><b>Operating Cash Flow of $1.7 Million</b></i>
</li>
<li class="bwlistitemmargb">
<i><b>Updates Fiscal Year 2011 Guidance</b></i>
</li>
<li class="bwlistitemmargb">
<i><b>Conference Call Today at 4:30 p.m. Eastern Time</b></i>
</li>
</ul>

Sep 09, 2010
AngioDynamics to Participate At Upcoming Investor Conferences
ALBANY, N.Y., Sep 09, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that management will present at upcoming investor conferences during the month
Sep 07, 2010
AngioDynamics Reports Preliminary Fiscal 2011 First Quarter Results
ALBANY, N.Y., Sep 07, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO) , a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today reported preliminary unaudited results for its fiscal 2011 first quarter ended August
Jul 15, 2010
AngioDynamics Reports Strong Finish to Fiscal 2010

<ul>
<li class="bwlistitemmarginbottom">
<i><b>Fourth Quarter Net Sales Increase 14% to $60.3 Million</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>First $1.0 Million NanoKnife(R) IRE System Net Sales Quarter</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>Record $16.1 Million Operating Cash Flow Quarter</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>Fourth Quarter Net Income Grows 29%</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>Company Provides Guidance for FY 2011</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>Conference Call Begins Today at 4:30 p.m. Eastern Time</b></i>
</li>
</ul>

Displaying 281 - 300 of 687